MARKET

APLS

Apellis Pharmace
APLS
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
231.15
5.18
12.65
5,252,712,995.31
A Look At Apellis Pharmaceuticals (APLS) Valuation After The Biogen Acquisition Announcement
Simply Wall St · 05/16 18:43
Cantor Fitzgerald Suspends Neutral Rating on Apellis Pharmaceuticals
Benzinga · 05/15 12:28
Why Is Biogen Stock Falling Thursday?
Benzinga · 05/14 15:57
XBI, APLS, TGTX, TVTX: Large Inflows Detected at ETF
NASDAQ · 05/14 14:59
Apellis Completes Biogen Merger and Goes Private
TipRanks · 05/14 13:22
After Hours Most Active for May 13, 2026 : CSCO, APLS, ITUB, PFE, RELY, NVDA, NOK, ALHC, AAPL, KVUE, BBD, SLB
NASDAQ · 05/13 23:59
Healthcare stocks with A+ momentum investors are watching
Seeking Alpha · 05/12 15:01
Analysts Have Conflicting Sentiments on These Healthcare Companies: Apellis Pharmaceuticals (APLS), Fractyl Health, Inc. (GUTS) and Inhibrx Biosciences Inc (INBX)
TipRanks · 05/11 14:10
More

Webull offers Apellis Pharmace stock information, including NASDAQ: APLS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, APLS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading APLS stock methods without spending real money on the virtual paper trading platform.